Biodesix Inc (NASDAQ:BDSX) price on Thursday, June 12, fall -6.16% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.30.
A look at the stock’s price movement, the close in the last trading session was $0.32. Turning to its 52-week performance, $2.04 and $0.17 were the 52-week high and 52-week low respectively. Overall, BDSX moved -16.49% over the past month.
Biodesix Inc’s market cap currently stands at around $43.95 million, with investors looking forward to this quarter’s earnings report slated for in July.
Analysts have a consensus estimate of 18.47M for the company’s revenue for the quarter, with a low and high estimate of 17.9M and 19.1M respectively. The average forecast suggests up to a 3.02% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 82.02M, representing a 14.99% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BDSX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend BDSX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BDSX’s current price about -3.79% and -29.94% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.76, while 7-day volatility ratio is 8.94% and 12.61% in the 30-day chart. Further, Biodesix Inc (BDSX) has a beta value of 0.99, and an average true range (ATR) of 0.05. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $3. Looking at the price targets, the low is -900.0% off current price level while to achieve the yearly target high, price needs to move -900.0%. Nonetheless, investors will most likely welcome a -900.0% jump to $3 which is the analysts’ median price.
If we refocus on Biodesix Inc (NASDAQ:BDSX), historical trading data shows that trading volumes averaged 8.47 million over the past 3 months. The company’s latest data on shares outstanding shows there are 146.44 million shares.
The 52.65% of Biodesix Inc’s shares are in the hands of company insiders while institutional holders own 36.42% of the company’s shares. Current price change has pushed the stock -80.40% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BDSX stock continues to rise going into the next quarter.
